These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1911373)

  • 1. Deletion of one GM-CSF allele and rearrangement of the other in a patient with myelodysplastic syndrome: possible loss of functions of a tumour suppressor gene closely linked to the GM-CSF locus on chromosome 5.
    Li YS; Luke B; Wang HS; Aye MT; Cheng G
    Br J Haematol; 1991 Sep; 79(1):126-7. PubMed ID: 1911373
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression and genomic configuration of GM-CSF, IL-3, M-CSF receptor (C-FMS), early growth response gene-1 (EGR-1) and M-CSF genes in primary myelodysplastic syndromes.
    Mareni C; Sessarego M; Montera M; Fugazza G; Origone P; D'Amato E; Lerza R; Pistoia V; Scarra GB
    Leuk Lymphoma; 1994 Sep; 15(1-2):135-41. PubMed ID: 7858491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Parallel loss of c-FMS and GM-CSF genes in myeloid leukemias with 5q-chromosome].
    Tanaka K; Takechi M; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Kyo T; Dohy H
    Rinsho Ketsueki; 1991 Sep; 32(9):931-7. PubMed ID: 1942539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Refractory anemia with 5q--anomaly. Clinical picture and follow-up of seven patients].
    May D; Becher R
    Med Klin (Munich); 1992 Aug; 87(8):408-11. PubMed ID: 1406472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [5q anomaly in myelodysplasia and acute myelocytic leukemia].
    Robak T
    Acta Haematol Pol; 1990; 21(2):235-42. PubMed ID: 2151871
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oncogenes and tumor suppressor genes: genetic changes mark the adenoma-carcinoma sequence].
    Schmiegel WH
    Internist (Berl); 1991 Jun; 32(6):315-20. PubMed ID: 1652573
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term disappearance of previous chromosomal abnormalities in myelodysplastic syndromes treated with low dose cytosine arabinoside and granulocyte/macrophage-colony stimulating factor.
    Sastre JL; Ulibarrena C; Bustillo M; Suárez-Gago M; García-Torremocha MS; Vázquez MO
    Haematologica; 1998 Aug; 83(8):763-5. PubMed ID: 9793271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the 5q- chromosome.
    Nagarajan L
    Leuk Lymphoma; 1995 May; 17(5-6):361-6. PubMed ID: 7549826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-kit ligand augments granulocyte-macrophage colony growth from patients with 5q- syndrome.
    Rosenfeld CS; Nemunaitis J; Sherer CR; Zeigler ZR; Shadduck RK
    Stem Cells; 1993 Nov; 11(6):562-7. PubMed ID: 7509225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q- anomaly.
    Huebner K; Isobe M; Croce CM; Golde DW; Kaufman SE; Gasson JC
    Science; 1985 Dec; 230(4731):1282-5. PubMed ID: 2999978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal evolution in a transforming 5q- syndrome.
    Kandioler D; Krieger O; Nowotny H; Lutz D
    Leukemia; 1994 Apr; 8(4):711-2. PubMed ID: 8152269
    [No Abstract]   [Full Text] [Related]  

  • 12. [*5q--syndrome].
    Yahata N; Ohyashiki K
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):187-90. PubMed ID: 9851117
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes.
    Estey EH; Kurzrock R; Talpaz M; McCredie KB; O'Brien S; Kantarjian HM; Keating MJ; Deisseroth AB; Gutterman JU
    Br J Haematol; 1991 Mar; 77(3):291-5. PubMed ID: 2012752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine transformation of human hematopoietic cells after transfection with an activated granulocyte/macrophage colony stimulating factor gene.
    Hoyle PE; Steelman LS; McCubrey JA
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):159-68. PubMed ID: 9426974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Towards an allotype of second generation colon cancer].
    Buecher B; Schmitz A; Lerebours F; Thuille B; Thomas G; Olschwang S
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1004-10. PubMed ID: 8729412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
    Boultwood J; Rack K; Kelly S; Madden J; Sakaguchi AY; Wang LM; Oscier DG; Buckle VJ; Wainscoat JS
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6176-80. PubMed ID: 1829836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Demonstration of two regions involved in chromosome 1p deletion in breast tumors].
    Bièche I; Champème MH; Matifas F; Cropp C; Callahan R; Lidereau R
    Bull Cancer; 1994 Feb; 81(2):108-13. PubMed ID: 7894115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders.
    Le Beau MM; Westbrook CA; Diaz MO; Larson RA; Rowley JD; Gasson JC; Golde DW; Sherr CJ
    Science; 1986 Feb; 231(4741):984-7. PubMed ID: 3484837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas.
    Revoltella RP; Menicagli M; Campani D
    Cytokine; 2012 Mar; 57(3):347-59. PubMed ID: 22200506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.